Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan
About this trial
This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).
Eligibility criteria
Qualifiers
Able to read, write and speak English
Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home
Physician diagnosis of fibromyalgia
OR: meet 2016 American College of Rheumatology (ACR) Criteria for FM: Widespread pain index score is ≥ 7 and symptom severity scale score is ≥ 5, or widespread pain index score is 4 to 6 and symptom severity score is ≥ 9
Disqualifiers
Indication of a co-occurring (non-fibromyalgia OR non-lupus) cause of chronic pain (e.g., inflammatory arthritis, other autoimmune disorders, spinal cord injury, cancer)
Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening.
Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols.
Trial design
Treatments tested in this trial
- Brief pain exposure therapy (BPET)
Treatment groups
125 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov